Explore Big Data At The Speed Of Thought

Video

See how interactive dashboards, predictive analytics and workflows designed for scientific data can help your organization create a complete picture of what’s happening, in real time.

Watch Now

Because BIG PCR happens in miniaturized packages

Video

In today's scientific environment, the pressure is on to do more with less. And how do you do that? With miniaturization. Miniaturization is the key for doing more with less in the life science industry. When you miniaturize reactions, you: . minimize sample volume . lower reagent cost . boost throughput Watch a short video of Dr. Luke Linz, LGC Laboratory Operations Manager, explaining how miniaturization works!

Watch Now

Efficient Silencing of mRNA and lncRNA with Fewer Off-target Effects

Featured Product

Exiqon LNA™ GapmeRs are powerful tools for loss of function studies of proteins, mRNA and lncRNAs.

Read more

Droplet Microfluidics

Infographic

Learn how microdroplets are generated, and some of the advantages they offer over conventional microfluidics

Read more
Cancer Cells Force Normal Cells to Act Like Viruses, Helping Tumors Spread

Cancer Cells Force Normal Cells to Act Like Viruses, Helping Tumors Spread

News

Researchers reveal how cancer cells force normal cells to act like viruses – allowing tumors to grow, resist treatment, and spread.

Read more
 
Innate Reaction of Hematopoietic Stem Cells to Severe Infections
News

Researchers at the University of Zurich have shown for the first time that hematopoietic stem cells detect infectious agents themselves and begin to divide, without signals from growth factors.

Read more

Cow Antibodies Yield Important Clues For Developing A Broadly Effective AIDS Vaccine
News

The unexpected animal model is providing clues for important questions at a moment when new energy has infused HIV vaccine research.

Read more

CRISPR Reveals New Targets for Promising Cancer Drugs
News

Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.

Read more